NCT00630630 Study on Safety and Efficacy of Levetiracetam in the Adjunctive Treatment of Female Subjects With C1 Catamenial Epilepsy Status COMPLETED Phase PHASE4
NCT00629889 Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors Status COMPLETED Phase PHASE2
NCT00627133 Efficacy of Keppra in Acute Alcohol Related Seizure Control--A Pilot Study Status WITHDRAWN Phase PHASE2
NCT00618436 Assess Safety and Efficacy of Levetiracetam(LEV;Keppra)for Seizure Prevention Status COMPLETED Phase PHASE4
NCT00615615 Efficacy and Tolerability of Levetiracetam Add-On Treatment in Refractory Pediatric Patients With Partial Onset Seizures Status COMPLETED Phase PHASE3
NCT00612859 Study to Assess the Efficacy and Safety of Levetiracetam for the Treatment of Social Anxiety Disorder (Generalized Type) Status COMPLETED Phase PHASE2
NCT00610454 Safety and Tolerability of Levetiracetam Intravenous 15 Minute Infusion in Subjects Suffering From Partial Onset Seizures Status COMPLETED Phase PHASE2
NCT00600509 Bridging Study of L059 (Levetiracetam) in Patients With Epilepsy by Double Blind Method Status COMPLETED Phase PHASE2
NCT00593125 Levetiracetam (Keppra) Tolerability in Cocaine Abusing Methadone-maintained Patients. Status COMPLETED Phase PHASE2
NCT00584025 Keppra IV for the Treatment of Motor Fluctuations in Parkinson's Disease Status WITHDRAWN Phase PHASE4
NCT00577005 Efficacy of Levetiracetam in Cocaine-Abusing Methadone Maintained Patients Status COMPLETED Phase PHASE2
NCT00571155 Trial of Levetiracetam in Patients With Primary Brain Tumors and Symptomatic Seizures Who Undergo Surgery Status COMPLETED Phase PHASE4
NCT00563459 Carisbamate Retention Study (CaReS): Comparative Study on the Long Term Effectiveness, Safety and Tolerability of Carisbamate Compared to Two Other Frequently Prescribed Anti-epileptic Drugs (AEDs) in Patients With Epilepsy. Status TERMINATED Phase PHASE3
NCT00545012 A Safety and Efficacy Follow-up Study With Levetiracetam in Children (4-17 Years Old) Suffering From Absence Seizures Status COMPLETED Phase PHASE2
NCT00544050 Pharmacokinetic Study of Levetiracetam in Epileptic Pediatric Subjects Ranging in Age From 1 Month to Less Than 4 Years Old Status COMPLETED Phase PHASE2
NCT00542802 Levetiracetam Versus Carbamazepine in Post-Stroke Late Onset Crisis Status UNKNOWN Phase PHASE3